 | |
| Names | |
|---|---|
| IUPAC name 11β,17α-Dihydroxypregn-4-ene-3,20-dione | |
| Systematic IUPAC name (1R,3aS,3bS,9aR,9bS,10S,11aS)-1-Acetyl-1,10-dihydroxy-9a,11a-dimethyl-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one | |
| Other names 21-Desoxycortisol; 21-Dehydrohydrocortisone; 21-Deoxyhydrocortisone; 11β,17α-Dihydroxyprogesterone | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| KEGG | |
| UNII | |
| |
| |
| Properties | |
| C21H30O4 | |
| Molar mass | 346.467 g/mol |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
21-Deoxycortisol, also known as11β,17α-dihydroxyprogesterone or as11β,17α-dihydroxypregn-4-ene-3,20-dione, is anaturally occurring,endogenoussteroid related tocortisol (11β,17α,21-trihydroxyprogesterone) which isformed as ametabolite from17α-hydroxyprogesterone via11β-hydroxylase.[1]
21-deoxycortisol is a marker ofcongenital adrenal hyperplasia due to 21-hydroxylase deficiency,[2][1][3] even in mild (non-classic) cases.[4][5] It can be also used for newborn screening.[6]
The deficiency of the21-hydroxylase enzyme leads to excess of17α-hydroxyprogesterone,[7][8] a 21-carbon (C21) steroid. This excess is accompanied by the accumulation of other C21 steroids, such as 21-deoxycortisol, which is formed by the 11β-hydroxylation of17α-hydroxyprogesterone[7] via11β-hydroxylase (CYP11B1).[1] The build-up of 21-deoxycortisol in patients withcongenital adrenal hyperplasia have been described since at least 1955, this steroid was then called "21-desoxyhydrocortisone".[9][10] Unlike17α-hydroxyprogesterone, 21-deoxycortisol is not produced in the gonads and is uniquely adrenal-derived. Hence, 21-deoxycortisol is a more specific biomarker of 21-hydroxylase deficiency than is17α-hydroxyprogesterone.[11]
Thecorticosteroid activity of 21-deoxycortisol is lower than that ofcortisol.[12][13]
As 21-deoxycortisol can be at high levels in congenital adrenal hyperplasia, and it has structural similarity tocortisol, it can cross-react inimmunoassays,[14][15][16] resulting in a falsely normal or high cortisol result, when the true cortisol is actually low. Whereasimmunoassays can suffer from cross-reactivity due to interactions with structural analogues, the selectivity offered byliquid chromatography-tandem mass spectrometry (LC-MS/MS) has largely overcome these limitations.[17][18][19] Hence, the use of LC-MS/MS instead of immunoassays in cortisol measurement aims to provide greater specificity.[20]
Besides 21-deoxycortisol, another C21 steroid, 21-deoxycorticosterone (11β-hydroxyprogesterone), has been proposed as a marker for 21-hydroxylase deficiency,[21][22][23] but this marker did not gain acceptance due to the fact that testing for the levels of this steroid is not routinely offered by diagnostic laboratories.[24]
